Page last updated: 2024-08-17

quinoxalines and Congestive Ophthalmopathy

quinoxalines has been researched along with Congestive Ophthalmopathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dayan, CM; Draman, MS; Grennan-Jones, F; Lane, C; Ludgate, M; Morris, D; Tee, AR; Zhang, L	1

Other Studies

1 other study(ies) available for quinoxalines and Congestive Ophthalmopathy

Article	Year
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7 Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Molecular Targeted Therapy; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Receptor, IGF Type 1; Receptors, Thyrotropin; Signal Transduction; Thiazolidinediones	2014

Article

Year

Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.

The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7

Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Molecular Targeted Therapy; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Receptor, IGF Type 1; Receptors, Thyrotropin; Signal Transduction; Thiazolidinediones

2014